From rare to revolutionary: how science can reach every patient

In a world where population health initiatives dominate the conversation, the needs of patients with the rarest conditions risk being overshadowed. But with over 3.5 million people living with a rare condition in the UK, these patients cannot be overlooked. Moreover, the science dedicated to these individuals holds profound potential, often driving innovations that redefine the boundaries of what is possible in healthcare.

From novel gene therapies to groundbreaking diagnostics, the lessons learned from addressing these exceptional challenges extend out to transform care for more common conditions. It’s a testament to how focusing on the rare can lead to extraordinary progress for all.

However, research and development in rare diseases require significant investment and face unique hurdles, such as limited patient populations for clinical trials and regulatory complexities. Despite these challenges, the stories of success in rare disease research, driven by relentless determination, patient advocacy, and scientific excellence, remind us of what’s possible when science refuses to overlook even the smallest patient groups.

Re:State is delighted to welcome Louise Fish, Chair of the Rare Diseases Advisory Group, NHS England, and Colin Wilson, Deputy Director of Research Infrastructure, Office for Life Sciences, Department of Health and Social Care, to lead this discussion.

This is a private event which will be held under the Chatham House rule and is kindly supported by UCB.